Safety and effectiveness of Lutetium-177-Prostate-Specific Membrane Antigen in patients with metastatic castration-resistant prostate cancer with and without visceral metastases who had received prior radium-223: a post hoc analysis of the RALU study

被引：0
|
作者：
Rahbar, Kambiz [1 ]
Essler, Markus [2 ]
Eiber, Matthias [3 ]
la Fougere, Christian [4 ]
Prasad, Vikas [5 ]
Pabst, Kim [6 ]
Fendler, Wolfgang [7 ]
Rassek, Philipp [8 ]
Hasa, Ergela [9 ]
Dittmann, Helmut [4 ]
Bundschuh, Ralph [10 ]
Kurtinecz, Milena [11 ]
Schmall, Anja [12 ]
Verholen, Frank [12 ]
Sartor, Oliver [13 ]
机构：
[1] Univ Hosp Munster, Dept Nucl Med, Munster, Germany
[2] Univ Hosp Bonn, Dept Nucl Med, Bonn, Germany
[3] Tech Univ Munich, Munich, Germany
[4] Univ Hosp Tubingen, Dept Nucl Med & Clin Mol Imaging, Tubingen, Germany
[5] Univ Ulm, Dept Nucl Med, Ulm, Germany
[6] Univ Hosp Essen, Dept Nucl Med, West German Canc, Essen, Germany
[7] Univ Hosp Essen, Essen, Germany
[8] Univ Munster, Dept Nucl Med, Med Ctr, Munster, Germany
[9] Tech Univ Munich, Nucl Med, Klinikum Rechts Isar, Munich, Germany
[10] Univ Hosp Augsburg, Nucl Med, Fac Med, Augsburg, Germany
[11] Bayer HealthCare Pharmaceut, Whippany, NJ USA
[12] Bayer Consumer Care, Basel, Switzerland
[13] Tulane Med Sch, Tulane Canc Ctr, New Orleans, LA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P607
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone-A Retrospective Study
    Chen, Hao Xiang
    Tsai, Li-Hsien
    Chang, Chao-Hsiang
    Wu, Hsi-Chin
    Lin, Ching-Chan
    Lin, Che-Hung
    Yeh, Chin-Chung
    Yang, Chi-Rei
    Lien, Chi-Shun
    Chang, Yi-Huei
    Liang, Ji-An
    Chen, Guan-Heng
    Hsiao, Po-Jen
    Hsieh, Po-Fan
    Huang, Chi-Ping
    CANCERS, 2023, 15 (13)
  • [32] Pain efficacy with radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the PARABO observational study
    Palmedo, H.
    Ahmadzadehfar, H.
    Eschmann, S.
    Selkinski, I.
    Straube, F.
    Niesen, A.
    Schoenberger, J.
    Barsegian, V.
    Liepe, K.
    Mottaghy, F. M.
    Guan, R.
    Pinkert, J.
    Buetikofer, S.
    Herrmann, K.
    ANNALS OF ONCOLOGY, 2021, 32 : S641 - S641
  • [33] 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
    Baum, Richard P.
    Kulkarni, Harshad R.
    Schuchardt, Christiane
    Singh, Aviral
    Wirtz, Martina
    Wiessalla, Stefan
    Schottelius, Margret
    Mueller, Dirk
    Klette, Ingo
    Wester, Hans-Juergen
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (07) : 1006 - 1013
  • [34] Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer
    O'Sullivan, Joe M.
    McKay, Rana R.
    Rahbar, Kambiz
    Fizazi, Karim
    George, Daniel J.
    Tombal, Bertrand
    Schmall, Anja
    Sandstrom, Per
    Verholen, Frank
    Shore, Neal
    FRONTIERS IN MEDICINE, 2022, 9
  • [35] Safety and effectiveness of the radium-223-taxane treatment sequence in patients with metastatic castration-resistant prostate cancer in a global observational study (REASSURE)
    Higano, Celestia S.
    Dizdarevic, Sabina
    Logue, John
    Richardson, Timothy
    George, Saby
    de Jong, Igle
    Tomaszewski, Jeffrey J.
    Saad, Fred
    Miller, Kurt
    Meltzer, Jeffrey
    Sandstroem, Per
    Verholen, Frank
    Tombal, Bertrand
    Sartor, Oliver
    CANCER, 2024, 130 (11) : 1930 - 1939
  • [36] Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study
    Zhou, Tie
    Zhou, Fangjian
    Guo, Jianming
    Shi, Hongcheng
    Yao, Xudong
    Guo, Hongqian
    Yuan, Jian
    Tian, Ye
    Zhang, Xiaodong
    Wang, Shuxia
    Jiang, Yongguang
    Zou, Qing
    Zhou, Daqing
    Li, Hanzhong
    Li, Fang
    Lee, Jae Lyun
    Chen, Chung-Hsin
    Park, Se Hoon
    Ng, Quan Sing
    Ma, Jianhui
    Zheng, Rong
    Ding, Qiang
    Liu, Xingdang
    Li, Rui
    Krissel, Heiko
    Wagner, Volker J.
    Sun, Yinghao
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (06) : 462 - 470
  • [37] UTILIZATION OF RADIUM-223 DICHLORIDE (RA-223) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CANADA: A REAL-WORLD RETROSPECTIVE STUDY
    Lapierre, M.
    Fraelic, A.
    VALUE IN HEALTH, 2016, 19 (03) : A162 - A162
  • [38] Pain evaluation in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in the PARABO observation study
    Palmedo, H.
    Eschmann, S.
    Werner, A.
    Selinski, I.
    Moellers, M-O.
    Kalinovsky, J.
    Benson, A.
    Poeppel, T.
    ANNALS OF ONCOLOGY, 2019, 30 : 336 - 336
  • [39] Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study
    Romero-Laorden, Nuria
    Lorente, David
    de Velasco, Guillermo
    Lozano, Rebeca
    Herrera, Bernardo
    Puente, Javier
    Lopez, Pedro P.
    Medina, Ana
    Almagro, Elena
    Gonzalez-Billalabeitia, Enrique
    Villla-Guzman, Jose Carlos
    Gonzalez-del-Alba, Aranzazu
    Borrega, Pablo
    Lainez, Nuria
    Fernandez-Freire, Ana
    Hernandez, Amaia
    Rodriguez-Vida, Alejo
    Chirivella, Isabel
    Fernandez-Parra, Eva
    Lopez-Campos, Fernando
    Pacheco, Maria Isabel
    Morales-Barrera, Rafael
    Fernandez, Ovidio
    Villatoro, Rosa
    Luque, Raquel
    Hernando, Susana
    Castellano, Daniel C.
    Castro, Elena
    Olmos, David
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 447 - 455
  • [40] A single-center retrospective analysis of the effect of Radium-223 (Xofigo) on pancytopenia in patients with metastatic castration-resistant prostate cancer.
    Skelton, William Paul
    Dibenedetto, Samantha Welniak
    Pang, Sarah
    Pan, Kelsey
    Barish, Jacob
    Nwosu-Iheme, Adaeze
    Dang, Long H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345